Repligen
RGEN
#2614
Rank
HK$53.03 B
Marketcap
HK$940.41
Share price
4.14%
Change (1 day)
4.24%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : HK$6.60 Billion

According to Repligen 's latest financial reports the company's total liabilities are HK$6.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$6.56 B-1.34%
2024-12-31HK$6.65 B-1.67%
2023-12-31HK$6.76 B39.47%
2022-12-31HK$4.85 B2.28%
2021-12-31HK$4.74 B63.71%
2020-12-31HK$2.89 B9.3%
2019-12-31HK$2.65 B112.81%
2018-12-31HK$1.24 B4.9%
2017-12-31HK$1.18 B27.44%
2016-12-31HK$0.93 B411.77%
2015-12-31HK$0.18 B41.73%
2014-12-31HK$0.12 B12.24%
2013-12-31HK$0.11 B14.58%
2012-12-31HK$99.87 M
2011-03-31HK$40.5 M-1.59%
2010-03-31HK$41.15 M14.67%
2009-03-31HK$35.89 M-2.54%
2008-03-31HK$36.82 M33.24%
2007-03-31HK$27.63 M12.04%
2006-03-31HK$24.66 M-4.61%
2005-03-31HK$25.86 M35.53%
2004-03-31HK$19.08 M9.05%
2003-03-31HK$17.49 M-15.88%
2002-03-31HK$20.79 M112.22%
2001-03-31HK$9.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$950.78 B 14,289.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$444.95 B 6,634.12%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$871.56 B 13,090.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$560.29 B 8,379.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.64 B-90.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$10.21 B 54.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$10.79 B 63.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$4.00 B-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.80 B 78.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$30.73 B 365.19%๐Ÿ‡บ๐Ÿ‡ธ USA